| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/16/2011 | CN101985467A Analgesic active peptide VGG and preparation method and applications thereof |
| 03/16/2011 | CN101985466A MBD recombinant protein and expression method thereof |
| 03/16/2011 | CN101985465A Soybean GmPHR1 gene and encoded protein and application thereof |
| 03/16/2011 | CN101985464A High-stability PAC1 type receptor specific agonist MPAPO and preparation method and application thereof |
| 03/16/2011 | CN101985443A Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 03/16/2011 | CN101985437A Naphtha uracil peptide nucleic acid (PNA) monomer, intermediate thereof as well as preparation methods and applications thereof |
| 03/16/2011 | CN101985036A Amyloid- beta (1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 03/16/2011 | CN101475949B Preparation of streptavidin labeled phycocyanin alpha subunit fluorescent protein combined with phycoerythrobilin |
| 03/16/2011 | CN101307316B Secretion expression of antibiotic peptide CAD in bacillus subtilis and expression system of recombination bacillus subtilis |
| 03/16/2011 | CN101186639B Fusion protein and its coding gene and use |
| 03/15/2011 | US7908094 Method for preparing maltogenic alpha-amylase variants |
| 03/15/2011 | US7906712 Tomato hybrid annamay |
| 03/15/2011 | US7906701 p300 transgenic animal |
| 03/15/2011 | US7906640 Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses |
| 03/15/2011 | US7906638 Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains |
| 03/15/2011 | US7906636 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 03/15/2011 | US7906634 HEMCM42 nucleic acids |
| 03/15/2011 | US7906629 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/15/2011 | US7906628 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 03/15/2011 | US7906627 Chimeric human sweet-umami and umami-sweet taste receptors |
| 03/15/2011 | US7906622 IL-D80 polypeptides and IL-27 |
| 03/15/2011 | US7906621 Anti-tumor drug, medicament, composition, and use thereof |
| 03/15/2011 | US7906620 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 03/15/2011 | US7906616 Truncated DANCE, DANCE complex and method of using these |
| 03/15/2011 | US7906482 Peptide YY (PYY) coupled to a group capable of reacting on a blood component so as to form a stable covalent bond, preventing said PYY peptide from crossing the blood brain barrier; improved bioavailability; reduce tumor necrosis factor (TNF)-induced acute pancreatitis |
| 03/15/2011 | US7906477 Proteases of human kallikrein 2 (hK2); tissue imaging |
| 03/15/2011 | US7906331 Methods for identifying stem cells expressing breast cancer resistance protein (BCRP) |
| 03/15/2011 | US7906328 Cell lines that express hetero oligomeric taste receptors |
| 03/15/2011 | US7906307 Transforming the Bacillus cell with a heterologous nucleotide sequence encoding a lipid acyltransferase, expressing the lipid acyltransferase in the cell, transforming the Bacillus licheniformis cell with a heterologous nucleotide sequence, expressing the lipid acyltransferase |
| 03/15/2011 | US7906306 Pullulanase variants and methods for preparing such variants with predetermined properties |
| 03/15/2011 | US7906277 Compound and methods for diagnosis of tuberculosis |
| 03/15/2011 | US7906150 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium |
| 03/15/2011 | US7906118 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology |
| 03/15/2011 | US7906111 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor |
| 03/15/2011 | CA2538085C Synthetic antimicrobial polypeptides |
| 03/15/2011 | CA2529062C Antimicrobial polypeptides |
| 03/15/2011 | CA2494698C Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 03/15/2011 | CA2494063C Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 03/15/2011 | CA2452005C Inhibition of apoptosis process and improvement of cell performance |
| 03/15/2011 | CA2429134C A method for generating genetically altered antigens |
| 03/15/2011 | CA2410297C Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 03/15/2011 | CA2389302C Delivery of proteins across polar epithelial cell layers |
| 03/15/2011 | CA2380833C Proteins derived from white spot syndrome virus and uses thereof |
| 03/15/2011 | CA2338982C Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 03/15/2011 | CA2202875C Process for purifying factor viii |
| 03/15/2011 | CA2188422C Bifunctional protein, preparation and use |
| 03/10/2011 | WO2011029008A2 Synbodies to akt1 |
| 03/10/2011 | WO2011028983A1 Treatment of diseases caused by bacterial exotoxins |
| 03/10/2011 | WO2011028963A2 Immunogenic hiv composition |
| 03/10/2011 | WO2011028950A1 Mutant smoothened and methods of using the same |
| 03/10/2011 | WO2011028643A1 Methods for improving malic acid production in filamentous fungi |
| 03/10/2011 | WO2011028485A2 Tumoricidal, bactericidal, or viricidal macrophage activation |
| 03/10/2011 | WO2011028344A2 Interleukin-1 receptor antagonist compositions and methods of making and using same |
| 03/10/2011 | WO2011028229A1 Coagulation factor ix compositions and methods of making and using same |
| 03/10/2011 | WO2011027941A1 Wnt10-derived peptide and use thereof |
| 03/10/2011 | WO2011027916A1 Therapeutic agent for allergic diseases |
| 03/10/2011 | WO2011027850A1 Bone regeneration agent including gelatin |
| 03/10/2011 | WO2011027839A1 Cholesterol-efflux peptide |
| 03/10/2011 | WO2011027796A1 Pentose transporter |
| 03/10/2011 | WO2011027738A1 Molecular probe for imaging islets of langerhans, and use therefore |
| 03/10/2011 | WO2011027342A2 Multi-site modified sp1 polypeptides and uses thereof |
| 03/10/2011 | WO2011027151A1 Stable manufacture of factor viii |
| 03/10/2011 | WO2011027129A1 Treatment of vasculoproliferative conditions |
| 03/10/2011 | WO2011027089A1 Quick extraction of cellular hepatotoxins |
| 03/10/2011 | WO2011026906A2 Novel microorganism and its use in lignocellulose detoxification |
| 03/10/2011 | WO2011026351A1 A cyanovirin n mutant, modified derivative and uses thereof |
| 03/10/2011 | WO2011026242A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| 03/10/2011 | WO2011018672A8 Methods and substances for stimulating muscle regeneration |
| 03/10/2011 | WO2011009044A3 A mechanism and method for regulating glycogen synthase kinase 3 (gsk3)-related kinases |
| 03/10/2011 | WO2011008348A3 Dual vector for inhibition of human immunodeficiency virus |
| 03/10/2011 | WO2011000860A3 Human polypeptides that interact with hiv and htlv proteins |
| 03/10/2011 | WO2010149743A3 Vaccine |
| 03/10/2011 | WO2010148511A8 Chimeric influenza virus-like particles comprising hemagglutinin |
| 03/10/2011 | WO2010139736A3 Recombinant production of peptides |
| 03/10/2011 | WO2010129655A3 Natriuretic polypeptides having mutations within their disulfide rings |
| 03/10/2011 | WO2010129347A3 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| 03/10/2011 | WO2010128521A3 Short-chain peptides as parathyroid hormone (pth) receptor agonist |
| 03/10/2011 | WO2010120121A3 Target-specific non-antibody protein and method for preparing the same |
| 03/10/2011 | WO2010120054A3 Environmental stress-inducible 972 promoter isolated from rice and uses thereof |
| 03/10/2011 | WO2010110596A3 Method for differentiation of stem cells into vascular cells and the induction of angiogenesis using the same |
| 03/10/2011 | US20110061137 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 03/10/2011 | US20110061136 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
| 03/10/2011 | US20110061132 Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake |
| 03/10/2011 | US20110061125 Genes and proteins for controlling flowering time, and use of the same |
| 03/10/2011 | US20110060580 Lxr ligand binding domain (lxr lbd) crystals |
| 03/10/2011 | US20110060129 Noncovalent collagen crosslinking agent |
| 03/10/2011 | US20110060128 Process for the purification of interleukin-4 and its muteins |
| 03/10/2011 | US20110060127 Structure Of Compstatin-C3 Complex And Use For Rational Drug Design |
| 03/10/2011 | US20110060126 Method and apparatus for optimizing crystallization conditions of a substrate |
| 03/10/2011 | US20110060124 Hla-binding peptides, precursors thereof, dna fragments and recombinant vectors that code for those peptide sequences |
| 03/10/2011 | US20110060123 Charge conversional ternary polyplex |
| 03/10/2011 | US20110059901 Compositions and Methods for Treatment of Neoplastic Disease |
| 03/10/2011 | US20110059897 Methods for treating a skin wound |
| 03/10/2011 | US20110059890 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 03/10/2011 | US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn |
| 03/10/2011 | US20110059887 Meal-time insulin analogues of enhanced stability |
| 03/10/2011 | US20110059885 Treatment of diseases and conditions mediated by eicosanoids |
| 03/10/2011 | US20110059859 Molecule Detecting System |
| 03/10/2011 | US20110059855 Use of adiponectin for the diagnosis and/or treatment of presbycusis |
| 03/10/2011 | US20110059851 SHOC2 Mutations Causing Noonan-Like Syndrome With Loose Anagen Hair |